NASH and NAFLD in HIV: same or different? | Mariana Machado, MD
Speaker: Mariana Machado, MD
Presented at Session 8: Liver complication (hepatitis related)
International Workshop on HIV & Hepatitis Co-infection 2017
For more medical education programs, as well as the latest scientific information, visit: https://academicmedicaleducation.com/
Видео NASH and NAFLD in HIV: same or different? | Mariana Machado, MD канала Academic Medical Education
Presented at Session 8: Liver complication (hepatitis related)
International Workshop on HIV & Hepatitis Co-infection 2017
For more medical education programs, as well as the latest scientific information, visit: https://academicmedicaleducation.com/
Видео NASH and NAFLD in HIV: same or different? | Mariana Machado, MD канала Academic Medical Education
Показать
Комментарии отсутствуют
Информация о видео
22 марта 2021 г. 16:37:06
00:16:28
Другие видео канала
Invitation to Asia-Pacific HIV Clinical Forum 2021 by Session Chair - Kiat Ruxrungtham, MD
Global Challenges in Hepatitis B Treatment - Ivan Antunez-Gonzalez
A new model for early clinical development of TB drugs and its application... | Norbert Heinrich, MD
Clinical Considerations of Aging People Living with HIV - Marta Boffito
The ABC of viral hepatitis | Mark Thursz, MRCP
Updates on WHO HIV Treatment Guidelines - Fujie Zhang, MD, PhD
Healthy Living with HIV Workshop: Session 4 | Live Style with HIV
Is HCV drug resistance an issue? | Jürgen Rockstroh, MD
Is NAFLD/NASH a Public Health Challenge in 2022? - Zobair M. Younossi, MD, MPH, FACG, FACP, AGAF
Immunology and Inflammation - Victor Appay, PhD
Long Acting Antivirals for Treatment and Prevention | Martin Markowitz, MD
Exercise and aging | Wendy Kohrt, PhD
Стигма и дискриминация в контексте группы людей, употребляющих инъекционные наркотики - Петр Мейлахс
Symposium 1: ViiV - What’s New in HIV Treatment & Prevention for Youth? - Panel Discussion
Invitation to join the HIV Prevention Review Meeting 2022 - 30-31 March
Pharmacological Considerations in Choice of Regimen - Saye Khoo, MD, PhD
Case-Based Discussion of Oral Antivirals for COVID-19: Part 1 - Catia Marzolini, PharmD, PhD
SARS-CoV-2 Virology, Persistence, and Inflammation - Michael Peluso, MD
Research into Aging with HIV: Lessons Learned and Outstanding Challenges - Peter Reiss
State of the Art Interventions in Improving Pediatric HIV Outcomes in OVC Programs - Grace Mayanja